Product Profiles
vericiguat : Chronic heart failure (CHF)

LIST OF FIGURES
Figure 1: Vericiguat for chronic heart failure – SWOT analysis
Figure 2: Datamonitor Healthcare’s drug assessment summary of vericiguat for chronic heart failure
Figure 3: Datamonitor Healthcare’s drug assessment summary of vericiguat for chronic heart failure
Figure 4: Vericiguat sales for chronic heart failure across the US, Japan, and five major EU markets, by country, 2017–26

LIST OF TABLES
Table 1: Vericiguat drug profile
Table 2: Vericiguat Phase III trials in chronic heart failure
Table 3: Vericiguat Phase II data in chronic heart failure
Table 4: Vericiguat sales for chronic heart failure across the US, Japan, and five major EU markets, by country ($m), 2017–26